|
LSM6 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.759380E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.013500E-02 |
| Normal-vs-Stage2 |
9.064400E-01 |
| Normal-vs-Stage3 |
4.443200E-01 |
| Normal-vs-Stage4 |
8.994200E-01 |
| Stage1-vs-Stage2 |
2.386600E-01 |
| Stage1-vs-Stage3 |
5.661600E-01 |
| Stage1-vs-Stage4 |
3.597400E-01 |
| Stage2-vs-Stage3 |
5.561800E-01 |
| Stage2-vs-Stage4 |
9.999800E-01 |
| Stage3-vs-Stage4 |
5.638800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.362400E-01 |
| Normal-vs-AfricanAmerican |
8.286000E-01 |
| Normal-vs-Asian |
1.941780E-01 |
| Caucasian-vs-AfricanAmerican |
4.458200E-01 |
| Caucasian-vs-Asian |
6.729900E-02 |
| AfricanAmerican-vs-Asian |
2.507400E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
7.149900E-02 |
| Normal-vs-Female |
9.521000E-01 |
| Male-vs-Female |
1.465780E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
7.312400E-01 |
| Normal-vs-Extreme_Weight |
2.278600E-01 |
| Normal-vs-Obese |
7.159000E-01 |
| Normal-vs-Extreme_Obese |
4.916000E-01 |
| Normal_Weight-vs-Extreme_Weight |
5.600200E-01 |
| Normal_Weight-vs-Obese |
9.975200E-01 |
| Normal_Weight-vs-Extreme_Obese |
5.092600E-01 |
| Extreme_Weight-vs-Obese |
5.362000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
7.417600E-01 |
| Obese-vs-Extreme_Obese |
5.138200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
8.143200E-01 |
| Normal-vs-Age(41-60Yrs) |
3.987200E-01 |
| Normal-vs-Age(61-80Yrs) |
1.792430E-01 |
| Normal-vs-Age(81-100Yrs) |
2.934600E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
5.249800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.050000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.801800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.156000E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.182200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
5.773600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.456800E-01 |
| Normal-VS-Type2 PRCC |
8.376800E-03 |
| Normal-VS-KIRP CIMP |
6.714800E-01 |
| Normal-VS-Unclassified PRCC |
8.628300E-02 |
| Type1 PRCC-VS-Type2 PRCC |
1.869730E-02 |
| Type1 PRCC-VS-KIRP CIMP |
5.403400E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.867230E-01 |
| Type2 PRCC-VS-KIRP CIMP |
1.159840E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
6.424400E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
1.792040E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
8.162100E-02 |
| Normal-vs-N1 |
9.250800E-01 |
| Normal-vs-N2 |
7.813800E-01 |
| N0-vs-N1 |
1.962820E-01 |
| N0-vs-N2 |
6.635200E-01 |
| N1-vs-N2 |
8.458400E-01 |
|
|
